6,513 followers
New research: Advances in Cellular Therapy for T-Cell Prolymphocytic Leukemia: T-cell prolymphocytic leukemia (T-PLL) is a rare, aggressive hematologic malignancy with a poor prognosis. Alemtuzumab (Campath) remains the cornerstone for… https://t.co/NzZmta